Sai Life Sciences Limited has informed the Exchange regarding a press release dated September 18, 2025, titled "Intimation for Opening of Unit VI, a dedicated facility for Veterinary API production in Bidar, India ".
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has announced the opening of Unit VI, a new manufacturing facility located in Bidar, India. The unit is dedicated to producing Active Pharmaceutical Ingredients (APIs) for the veterinary segment, marking a focused expansion into animal healthcare manufacturing. This is part of the company's growth strategy to widen its manufacturing footprint and serve a new market segment. The announcement was made via a press release dated September 18, 2025.
The new veterinary API facility signals capacity expansion and diversification into the animal health segment, which could open an additional revenue stream for the company. For shareholders, this is a positive growth signal, though the actual impact on earnings will depend on the facility's scale, utilization, and client acquisitions.